MYX mayne pharma group limited

Ann: 2024 Half Year Investor Presentation, page-19

  1. 369 Posts.
    lightbulb Created with Sketch. 205
    Also agree P31,with regards to buyback.
    As long as the sales are growing the buyback is safe.
    If something hits a speed bump in relation to growth....the buyback may be scaled back.

    The canary in the coalmine for me is two fold,
    - 1st virburnum staying on the registry
    - 2 if the buyback is paired back or halted.....we will know the numbers aren't building quickly enough (ie lower revenue,..hence profit)
    These are my two cue's to review my position/ exit.

    AIMHO
    Last edited by flyer100: 26/02/24
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$5.25
Change
-0.150(2.78%)
Mkt cap ! $426.5M
Open High Low Value Volume
$5.35 $5.41 $5.19 $1.239M 231.7K

Buyers (Bids)

No. Vol. Price($)
1 1000 $5.17
 

Sellers (Offers)

Price($) Vol. No.
$5.36 1000 1
View Market Depth
Last trade - 16.11pm 25/07/2025 (20 minute delay) ?
MYX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.